Characterizing TDP-43 involvement in vascular dementia.

Area of Science:

• Neuroscience
• Neuropathology
• Molecular Biology

Background:

• Vascular dementia (VaD) presents significant therapeutic challenges.
• TDP-43, a key protein in neurodegeneration, is implicated in VaD pathogenesis under chronic cerebral hypoperfusion (CCH).
• Understanding TDP-43's role is crucial for developing effective VaD treatments.

Purpose of the Study:

• To investigate the dysregulation of TDP-43 in vascular dementia.
• To determine if TDP-43 abnormalities are specific to VaD under hypoperfusion.
• To explore TDP-43 as a potential early biomarker for VaD.

Main Methods:

• Assessed TDP-43 and phosphorylated TDP-43 (pTDP-43) expression and localization in a VaD animal model (BCAS).
• Examined TDP-43 changes in neuronal cells subjected to oxygen-glucose deprivation (OGD) in vitro.
• Analyzed post mortem human brain tissues from VaD, Alzheimer's, and mixed dementia cases.

Main Results:

• CCH in the VaD model induced increased pTDP-43 and aberrant redistribution of TDP-43 and pTDP-43.
• In vitro OGD mimicked these TDP-43 mislocalization effects.
• No TDP-43 abnormalities were found in post mortem VaD brains, contrasting with marked pathology in Alzheimer's and mixed dementia.

Conclusions:

• TDP-43 dysregulation is an early event in VaD associated with hypoperfusion.
• These early TDP-43 changes distinguish VaD from other dementia subtypes.
• TDP-43 represents a transient, novel molecular target for vascular cognitive impairment.